List of Oral Presentations

The following Oral Presentations will be delivered at Cancer & Autoimmunity 2018:

Speaker Title Institution Country
Gerardo E. Guillén, PhD. Pending Title Center for Genetic Engineering and Biotechnology, CIGB Cuba
Silvio E. Perea, PhD Protein Kinase CK2 as emerging oncology target: Lessons from the CIGB-300 peptide inhibitor. Head of the Molecular Oncology Laboratory and Cancer Council at the CIGB Cuba
Yasser Perera, PhD

Targeting of Protein Kinase CK2-mediated phoshorylation in Acute Myeloid Leukemia (AML).

Molecular Oncology Laboratory. Cancer Department. Biomedical Research Area. CIGB Cuba
Katherine Borden, PhD Targeting post-transcriptional regulation in cancer Principal Investigator, Structure and Function of the Cell Nucleus research unit, Institute for Research in Immunology and Cancer. Professor, Department of Pathology and Cell Biology, Faculty of Medicine, Université de Montréal, Canada. Canada
Renier J. Brentjens, MD, PhD CARS and ARMORED CARS Memorial Sloan Kettering Cancer Center. Department of Medicine, Leukemia Service. New York. EE.UU
Jose R. Conejo-Garcia, MD, PhD Chimeric Endocrine Receptors targeting the FSH Receptor enable T cells to block ovarian cancer progression without off-tumor toxicity Chair, Department of Immunology. Moffitt Cancer Center, Tampa, USA EE.UU
Frank J. Rauscher, III, Ph.D Gene regulation and crosstalk amongst innate immune factors in the Tumor Microenvironment:  treating the tumor  as an organ Caspar Wistar Professor and Founder, The Gene Expression and Regulation Program Wistar Professor, Department of Genetics, University of Pennsylvania, USA EE.UU

Luis Graca, MD. PhD.

Tfh and Tfr cells in human autoimmunity

Associate Professor, Head of Lymphocyte Regulation Laboratory, Faculdade de Medicina da Universidade de Lisboa, Portugal.

EE.UU

David Klatzmann, MD. PhD.

Pending Title

Lab Director, Professor of Immunology, Chief of Biotherapy, Coordinator of the Inflammatory-Immunopathology-Immunotherapy department and Coordinator of the Clinical Investigation Center in Biotherapy at Pierre and Marie Curie Medical School and Pitié-Salpêtrière hospital.

EE.UU

Willem van Eden

Pending Title

Professor, Department of Infectious Diseases and Immunology, Universiteit Utrecht.

EE.UU
Kelley Parato “Building a CAR: Structural Considerations”

Director Scientific Affairs at BioCanRx. Ottawa, Canada Area

Canada